Dr. Dalia Khalife joined Jumeirah American Clinic in August 2020. She completed a 4-year residency in Obstetrics and Gynecology at the American University of Beirut Medical Center followed by a 2-year fellowship in Reproductive Endocrinology and Infertility at the same institution. Upon completion of her fellowship, she pursued an 8 months training in fertility preservation and oncofertility at the Assisted Conception Unit at Guy’s and St Thomas’ Hospital in London where she was active in research and clinical care.
During her training, Dr. Khalife received multiple awards and presented in multiple national and international meetings. Her interest in research has granted her oral presentations in distinguished meetings such as the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE). Her project about fertility preservation in cancer survivors was presented recently at ESHRE and was featured by multiple medical journals in the UK. She also has published more than 15 articles, 6 book chapters in peer-reviewed journals and has multiple submitted and ongoing studies. She’s also pursuing a master’s in Clinical Embryology at the University of Leeds and will be graduating in December 2020.
Dr. Khalife has extensive experience in managing patients with infertility. She tailors the treatment according to the latest evidence-based medicine. Her experience includes the management of female and male infertility, ovulation induction, ovarian stimulation for in vitro fertilization (IVF) cycles, intrauterine insemination (IUI), transvaginal and abdominal egg retrievals, embryo transfer, diagnostic and operative hysteroscopies, 3D ultrasound and fertility-sparing laparoscopic surgeries.
Dr. Khalife is known for her excellent work ethic and interpersonal skills. She is well mannered and devoted to patients’ care. Moreover, she has a special interest in treating challenging patients such as patients with poor ovarian response, polycystic ovarian syndrome, endometriosis, and recurrent implantation failure. She is also experienced in counseling patients for fertility preservation (social and medical) and pre-implantation genetic testing.
Abstract released in the press program of ESHRE- July 2020
Live birth rate and utilization rate of eggs and embryos following fertility preservation in 879 female cancer patients over 19 years. 36th Annual Meeting of European Society of Human Reproduction and Embryology. Featured in the regional press:
- Fertility preservation is effective in female cancer patients. BioNews, United Kingdom. https://www.bionews.org.uk/page_150689.
- Fertility can be successfully preserved in breast cancer patients. News Medical Life Sciences, United Kingdom. – https://www.news-medical.net/news/20200706/Fertility-can-be-successfully-preserved-in-breast-cancer-patients-shows-study.aspx.
- Fertility hope rises for young women with cancer. The Times, United Kingdom. https://www.thetimes.co.uk/edition/news/fertility-hope-rises-for-young-women-with-cancer-wmbsktzjb.